Skip to main content
OPK
NASDAQ Life Sciences

OPKO Health Clarifies Urgency of New Equity Plan After Old Plan's Expiration

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$1.12
Mkt Cap
$830.601M
52W Low
$0.977
52W High
$1.6
52W Position info
15% above low
Off High info
30% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

OPK is trading near its 52-week low of $0.977 (15% above the low).

Summary

OPKO Health filed a proxy statement supplement clarifying that its 2016 Equity Incentive Plan expired in February 2026, making 19 million shares unavailable for future grants and underscoring the critical need for stockholder approval of the proposed 2026 Equity Incentive Plan.


Key Events · Corporate Governance and Compliance · OPK

  • Proxy Statement Supplement Filed

    This DEFA14A is a supplement to the definitive proxy statement filed on April 30, 2026, providing clarification on Proposal No. 2 regarding the 2026 Equity Incentive Plan.

  • Prior Equity Plan Expired

    The company's 2016 Equity Incentive Plan expired by its terms in February 2026.

  • 19 Million Shares No Longer Available

    19,008,162 shares that remained available for grant under the expired 2016 plan are no longer available for issuance.

  • New Plan Critical for Equity Compensation

    If the 2026 Equity Incentive Plan is not approved, the company will generally be unable to grant new equity awards, potentially leading to increased cash compensation and reduced long-term alignment with investors.


Analysis · OPK · Life Sciences

This filing clarifies the critical need for stockholder approval of the proposed 2026 Equity Incentive Plan. The previous 2016 plan expired in February, rendering 19 million shares unavailable for future grants. Without the new plan, OPKO Health cannot issue equity awards, which could force increased cash compensation, impacting cash flow and potentially hindering talent retention and long-term alignment with investors. The board's reassertion of its 'FOR' recommendation underscores the significance of this vote for the company's future compensation strategy.

At the time of this filing, OPK was trading at $1.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $830.6M. The 52-week trading range was $0.98 to $1.60. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OPK - Latest Insights

OPK
May 15, 2026, 4:38 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $1.12
Real-time Price: $1.52 info
Change: +$0.400 (+36%) info
Market Cap: $1.14B info
OPK
Apr 30, 2026, 4:01 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $1.52 info
Change: +$0.400 (+36%) info
Market Cap: $1.14B info
OPK
Apr 30, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.11
Real-time Price: $1.52 info
Change: +$0.410 (+37%) info
Market Cap: $1.14B info
OPK
Apr 28, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $1.52 info
Change: +$0.360 (+31%) info
Market Cap: $1.14B info
OPK
Apr 28, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $1.52 info
Change: +$0.3503 (+30%) info
Market Cap: $1.14B info
OPK
Apr 22, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.22
Real-time Price: $1.52 info
Change: +$0.2953 (+24%) info
Market Cap: $1.14B info
OPK
Apr 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $1.52 info
Change: +$0.320 (+27%) info
Market Cap: $1.14B info
OPK
Feb 26, 2026, 4:10 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $1.52 info
Change: +$0.3199 (+27%) info
Market Cap: $1.14B info
OPK
Feb 26, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.22
Real-time Price: $1.52 info
Change: +$0.300 (+25%) info
Market Cap: $1.14B info